Therefore, to determine whether the protective effect of PACAP against hypoglycaemia was mediated by PAC-1 activation, NSCs were pre-treated with the specific agonist for PAC-1; Max-4 (30 nM) [61], before exposing the cells to low glucose for 24 hours. The gene discussed is ADCYAP1; the disease is Hypoglycemia.